Image Credit: Vazyme
On November 15, 2021, Vazyme Biotech Co., Ltd. (hereinafter referred to as "Vazyme") was listed on SSE STAR Market. Stock abbreviation: Vazyme, stock code: 688105. The issue price is 55 yuan/share, and the opening price is 74 yuan/share.
As of September 30, 2021, the total assets of Vazyme were RMB 2,289.5032 million, an increase of 42.06% over the end of the previous year; the net assets attributable to shareholders of the parent company were RMB 1,888.0213 million, an increase of 41.70% over the end of the previous year.
Vazyme Biotech Co., Ltd. was established in 2012. It is a biotechnology company engaged in technological research and product development of functional proteins and polymer organic materials such as enzymes, antigens, antibodies, etc., relying on key common technologies established independently. The platform has successively entered the fields of biological reagents and in vitro diagnostics and is conducting research and development of antibody drugs. It is one of the few domestic R&D and innovative enterprises that have both independent and controllable upstream technology development capabilities and terminal product production capabilities.
